Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - Results from the CHIKARA study
International Journal of Rheumatic Diseases Sep 10, 2018
Tada M, et al. - In a prospective, observational study (CHIKARA study) of rheumatoid arthritis (RA) patients, experts gauged the associations between sarcopenia and disease activity, physical function, laboratory data, and body composition at baseline. In patients with RA whose disease activity was mild, the prevalence of sarcopenia was 28%. Findings suggested an independent association of low BMI, high-fat mass and high MMP3 with sarcopenia. A useful marker for sarcopenia in patients with RA could be MMP3. They noted an increase of 3.1-fold compared with < 90.7 ng/mL in the odds ratio for sarcopenia when MMP3 was ≥ 90.7 ng/mL.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries